CNXC Form 4: CEO exercised 9,363 options at $44.52 and bought 1,000 shares
Rhea-AI Filing Summary
Concentrix Corp director and President/CEO Christopher A. Caldwell reported three transactions on 09/30/2025. He acquired 1,000 shares of Common Stock at $47.435, exercised 9,363 employee stock options with an exercise price of $44.52, and had 8,990 shares withheld to satisfy the option exercise price and taxes. After these transactions the reported beneficial ownership totals shown on the form include 313,725 and similar post-transaction balances for direct holdings.
Positive
- Acquired 1,000 shares at $47.435 on 09/30/2025
- Exercised 9,363 employee stock options at an exercise price of $44.52
Negative
- None.
Insights
Insider exercised options and bought shares on 09/30/2025.
The filing shows the reporting person exercised 9,363 employee stock options at an exercise price of $44.52 and purchased 1,000 shares at $47.435. These are direct, reported transactions dated 09/30/2025.
The form also discloses 8,990 shares were withheld to satisfy the exercise price and taxes in a net (cashless) exercise, per the explanatory footnote. This explains why a portion of the exercised option shares did not increase reported share count.
Transactions reflect standard option exercise and withholding mechanics.
The options exercised carry a listed exercise price of $44.52 and were exercisable with an expiration shown as 10/06/2025 on the form, indicating these were employee stock options near their expiration window.
The form identifies the transactions as direct ownership (D), and a signature by an attorney-in-fact is dated 10/02/2025, evidencing timely reporting.
FAQ
What transactions did Christopher A. Caldwell report on the Form 4 for CNXC?
Were the option exercises reported as direct or indirect ownership on the Form 4?
What was the exercise price and expiration related to the reported options?
Why were 8,990 shares listed as disposed on the Form 4?
When was the Form 4 signed and filed on behalf of the reporting person?